125 related articles for article (PubMed ID: 29659940)
1. Risk factors for pericardial effusion after chemoradiotherapy for thoracic esophageal cancer-comparison of four-field technique and traditional two opposed fields technique.
Takata N; Kataoka M; Hamamoto Y; Tsuruoka S; Kanzaki H; Uwatsu K; Nagasaki K; Mochizuki T
J Radiat Res; 2018 May; 59(3):291-297. PubMed ID: 29659940
[TBL] [Abstract][Full Text] [Related]
2. Pericardial effusion after definitive concurrent chemotherapy and intensity modulated radiotherapy for esophageal cancer.
Pao TH; Chang WL; Chiang NJ; Lin CY; Lai WW; Tseng YL; Lin FC
Radiat Oncol; 2020 Feb; 15(1):48. PubMed ID: 32103779
[TBL] [Abstract][Full Text] [Related]
3. Symptomatic pericardial effusion after chemoradiation therapy in esophageal cancer patients.
Fukada J; Shigematsu N; Takeuchi H; Ohashi T; Saikawa Y; Takaishi H; Hanada T; Shiraishi Y; Kitagawa Y; Fukuda K
Int J Radiat Oncol Biol Phys; 2013 Nov; 87(3):487-93. PubMed ID: 23968770
[TBL] [Abstract][Full Text] [Related]
4. Analysis of cardiac toxicity after definitive chemoradiotherapy for esophageal cancer using a biological dose-volume histogram.
Takeuchi Y; Murakami Y; Kameoka T; Ochi M; Imano N; Takahashi I; Nishibuchi I; Kimura T; Kawahara D; Saito A; Nagata Y
J Radiat Res; 2020 Mar; 61(2):298-306. PubMed ID: 32052040
[TBL] [Abstract][Full Text] [Related]
5. Risk factors for pericardial effusion in patients with stage I esophageal cancer treated with chemoradiotherapy.
Tamari K; Isohashi F; Akino Y; Suzuki O; Seo Y; Yoshioka Y; Hayashi Y; Nishida T; Takehara T; Mori M; Doki Y; Ogawa K
Anticancer Res; 2014 Dec; 34(12):7389-93. PubMed ID: 25503178
[TBL] [Abstract][Full Text] [Related]
6. Dosimetric predictors of radiation-induced pericardial effusion in esophageal cancer.
Ogino I; Watanabe S; Sakamaki K; Ogino Y; Kunisaki C; Kimura K
Strahlenther Onkol; 2017 Jul; 193(7):552-560. PubMed ID: 28424841
[TBL] [Abstract][Full Text] [Related]
7. Pericardial and pleural effusions after definitive radiotherapy for esophageal cancer.
Fukada J; Shigematsu N; Ohashi T; Shiraishi Y; Takeuchi H; Kawaguchi O; Kitagawa Y
J Radiat Res; 2012; 53(3):447-53. PubMed ID: 22739014
[TBL] [Abstract][Full Text] [Related]
8. Toxic Effects of Volume-modulated Arc Therapy for Esophageal Squamous Cell Cancer: Preliminary Clinical Results.
Shigenaga D; Ichiro O; Watanabe S; Hata M
Anticancer Res; 2023 Jun; 43(6):2791-2798. PubMed ID: 37247893
[TBL] [Abstract][Full Text] [Related]
9. Long-term results of definitive concurrent chemoradiotherapy for patients with esophageal submucosal cancer (T1bN0M0).
Murakami Y; Takahashi I; Nishibuchi I; Doi Y; Okabe T; Kenjo M; Kimura T; Nagata Y
Int J Clin Oncol; 2015 Oct; 20(5):897-904. PubMed ID: 25800809
[TBL] [Abstract][Full Text] [Related]
10. Predictive factors for pericardial effusion identified by heart dose-volume histogram analysis in oesophageal cancer patients treated with chemoradiotherapy.
Hayashi K; Fujiwara Y; Nomura M; Kamata M; Kojima H; Kohzai M; Sumita K; Tanigawa N
Br J Radiol; 2015 Feb; 88(1046):20140168. PubMed ID: 25429644
[TBL] [Abstract][Full Text] [Related]
11. Dose-Response Relationship between Radiation Dose and Loco-regional Control in Patients with Stage II-III Esophageal Cancer Treated with Definitive Chemoradiotherapy.
Kim HJ; Suh YG; Lee YC; Lee SK; Shin SK; Cho BC; Lee CG
Cancer Res Treat; 2017 Jul; 49(3):669-677. PubMed ID: 27737537
[TBL] [Abstract][Full Text] [Related]
12. Risk factors for pericardial effusion in inoperable esophageal cancer patients treated with definitive chemoradiation therapy.
Wei X; Liu HH; Tucker SL; Wang S; Mohan R; Cox JD; Komaki R; Liao Z
Int J Radiat Oncol Biol Phys; 2008 Mar; 70(3):707-14. PubMed ID: 18191334
[TBL] [Abstract][Full Text] [Related]
13. Pericardial irradiation dose may be strongly associated with grade 4 lymphopenia and affect prognosis in patients with locally advanced esophageal cancer receiving definitive concurrent chemoradiotherapy.
Chen X; Tian X; Zhang X; Deng Q; Wang M; Zhou X; Xu Y; Zhou L; Zou B; Liu Y; Ao R; Lu Y; Gong Y
Thorac Cancer; 2023 Sep; 14(27):2735-2744. PubMed ID: 37519061
[TBL] [Abstract][Full Text] [Related]
14. A Contralateral Esophagus-Sparing Technique to Limit Severe Esophagitis Associated With Concurrent High-Dose Radiation and Chemotherapy in Patients With Thoracic Malignancies.
Al-Halabi H; Paetzold P; Sharp GC; Olsen C; Willers H
Int J Radiat Oncol Biol Phys; 2015 Jul; 92(4):803-10. PubMed ID: 26104934
[TBL] [Abstract][Full Text] [Related]
15. Acute cardiac impairment associated with concurrent chemoradiotherapy for esophageal cancer: magnetic resonance evaluation.
Hatakenaka M; Yonezawa M; Nonoshita T; Nakamura K; Yabuuchi H; Shioyama Y; Nagao M; Matsuo Y; Kamitani T; Higo T; Nishikawa K; Setoguchi T; Honda H
Int J Radiat Oncol Biol Phys; 2012 May; 83(1):e67-73. PubMed ID: 22365626
[TBL] [Abstract][Full Text] [Related]
16. Cardiac Toxicity in Operable Esophageal Cancer Patients Treated With or Without Chemoradiation.
Witt JS; Jagodinsky JC; Liu Y; Yadav P; Kuczmarska-Haas A; Yu M; Maloney JD; Ritter MA; Bassetti MF; Baschnagel AM
Am J Clin Oncol; 2019 Aug; 42(8):662-667. PubMed ID: 31313677
[TBL] [Abstract][Full Text] [Related]
17. Late toxicity after definitive concurrent chemoradiotherapy for thoracic esophageal carcinoma.
Morota M; Gomi K; Kozuka T; Chin K; Matsuura M; Oguchi M; Ito H; Yamashita T
Int J Radiat Oncol Biol Phys; 2009 Sep; 75(1):122-8. PubMed ID: 19327900
[TBL] [Abstract][Full Text] [Related]
18. [Thoracoscopic pericardial fenestration for persistent pericardial effusion after radiotherapy for esophageal cancer; report of a case].
Sakamoto K; Tsuchida K; Ariga T
Kyobu Geka; 2002 Nov; 55(12):1077-80. PubMed ID: 12428347
[TBL] [Abstract][Full Text] [Related]
19. Comparison of Definitive Chemoradiotherapy in Locally Advanced Esophageal Squamous Cell Carcinoma.
Yao B; Tan B; Wang C; Song Q; Wang J; Guan S; Jia Y; Ma Y; Huang X; Sun Y; Cheng Y
Ann Surg Oncol; 2016 Jul; 23(7):2367-72. PubMed ID: 26932711
[TBL] [Abstract][Full Text] [Related]
20. Induction chemoradiotherapy increases pleural and pericardial complications after esophagectomy for cancer.
Murthy SC; Rozas MS; Adelstein DJ; Mason DP; Calhoun R; Rybicki LA; Feng J; Blackstone EH; Rice TW
J Thorac Oncol; 2009 Mar; 4(3):395-403. PubMed ID: 19247086
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
